Skip to content

Evaluation of the effects of herbal medicine on improve diabetic patients

Evaluation of ZAX.1400.D.05 drug on hyperglycemia in type 2 diabetes patients; double blind clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220207053960N1
Enrollment
80
Registered
2023-06-12
Start date
2023-08-06
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: ZAX.1400.D.05 drug combination, in capsule formulation, is taken in three daily doses for 60 days. Intervention 2: Control group: The composition of popcorn corn fl

Sponsors

Fasa University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Confirmation of type 2 diabetes according to ADA criteria Age from 40 to 60 years Having informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Pregnancy and lactation History of allergies to herbal products Disagreement of the responsible physician of the patient before randomization

Design outcomes

Primary

MeasureTime frame
HBA1C. Timepoint: Zero days and 60 days after the start of the intervention. Method of measurement: Spectrophotometry.;FBS. Timepoint: Zero days and 60 days after the start of the intervention. Method of measurement: Auto analyzer.;Lipid profile. Timepoint: Zero days and 60 days after the start of the intervention. Method of measurement: Auto analyzer.;Liver enzymes. Timepoint: Zero days and 60 days after the start of the intervention. Method of measurement: Auto analyzer.;Kidney indicators. Timepoint: Zero days and 60 days after the start of the intervention. Method of measurement: Auto analyzer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmin Dakhili Ardestani

Fasa University of Medical Sciences

a.dakhili@fums.ac.ir+98 71 5335 9507

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026